Amthera Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 03-06-2024
- Paid Up Capital ₹ 0.10 M
as on 03-06-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -98.89%
(FY 2022)
- Profit 89.08%
(FY 2022)
- Ebitda 91.49%
(FY 2022)
- Net Worth -10.87%
(FY 2022)
- Total Assets -64.58%
(FY 2022)
About Amthera Life Sciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Tinani and Shankarappa Babu serve as directors at the Company.
- CIN/LLPIN
U74999KA2017PTC104317
- Company No.
104317
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2017
- Date of AGM
25 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Amthera Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Tinani  | Director | 05-Jun-2022 | Current |
| Shankarappa Babu | Director | 03-Jul-2017 | Current |
Financial Performance and Corporate Structure Insights of Amthera Life Sciences.
Amthera Life Sciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.89% decrease. The company also saw a substantial improvement in profitability, with a 89.08% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amthera Life Sciences?
In 2021, Amthera Life Sciences had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Peenya Food & Drug Testing Lab Private LimitedActive 7 years 5 months
Shankarappa Babu is a mutual person
- Biocraft School Of Pre-Clinicals Private LimitedActive 12 years 7 months
Shankarappa Babu is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amthera Life Sciences?
Unlock and access historical data on people associated with Amthera Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amthera Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amthera Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
